Notícias Summit Therapeutics Inc - SMMT | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Summit Therapeutics Inc (SMMT)
Summit Therapeutics Inc (SMMT) Notícias

Summit Therapeutics Inc (SMMT)

19,96

0,97

(5,11%)

Fechado 05 Novembro 6:00PM

Atrasado por 15 minutos

20,05

0,09

(0,45%)

Após o horário de negociação: 9:53PM

Atrasado por 15 minutos

Seu centro para cotações em tempo real, discussões ao vivo e novas ideias.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024

Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Promising Anti-Tumor Activity and Safety of Ivonescimab in Combination Therapies in CRC, TNBC, and HNSCC Featured at ESMO 2024

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Summit Therapeutics Raises $235 Million

Form 8-K - Current report

Ivonescimab Monotherapy Reduced the Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC in China

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Summit Therapeutics

Amundi Msci Europe Value...

iShares MSCI Finland ETF

TWC Enterprises

Addex Therapeutics

FORJA TAURUS PN

TRACON Pharmaceuticals

Verizon Communications, Inc.

Running Fox Resources (CE)

Lehman Abs Sprint A1

Indian Renew 22

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições